Results 201 to 210 of about 131,629 (255)
Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high-risk relapsed/refractory Hodgkin lymphoma. [PDF]
HemasphereMei M +17 more
europepmc +1 more source
Nationwide study of COVID-19 outcomes in hematologic patients following bone marrow transplantation. [PDF]
Sci RepGarcia-Carretero R +5 more
europepmc +1 more source
A Rare Presentation of a Devastating Disease: Hepatosplenic T-Cell Lymphoma in Crohn's Disease Without Thiopurine Exposure. [PDF]
ACG Case Rep JChang M +3 more
europepmc +1 more source
The causal association between psoriasis and 32 types of cancer: a mendelian randomization study. [PDF]
Discov OncolLi G, Tian J, Xu J, Li K.
europepmc +1 more source
Synchronous Lymphoma: Diagnostic Challenges in a Case of Coexisting Diffuse Large B-cell Lymphoma and Classical Hodgkin Lymphoma. [PDF]
CureusRana F +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Critical Reviews in Oncology/Hematology, 1992
The high success rate in the treatment of patients with Hodgkin’s disease is one of the greatest achievements in cancer therapeutics. The majority of patients with Hodgkin’s disease can be cured with current state-of-the-art management, due to cooperation of surgeons, radiation therapists, and oncologists.
Dwight Kaufman, Dan L. Longo
+13 more sources
The high success rate in the treatment of patients with Hodgkin’s disease is one of the greatest achievements in cancer therapeutics. The majority of patients with Hodgkin’s disease can be cured with current state-of-the-art management, due to cooperation of surgeons, radiation therapists, and oncologists.
Dwight Kaufman, Dan L. Longo
+13 more sources
Cancer Treatment Reviews, 1984
The outlook for patients with Hodgkin's disease has improved dramatically over the past 20 years. The question is no longer whether cure is possible, but rather, how can cure be best achieved. With better understanding of the biology of Hodgkin's disease and with continued evolution of treatment approaches, the goal of curing all patients with Hodgkin ...
Norbert Schmitz +3 more
openaire +6 more sources
The outlook for patients with Hodgkin's disease has improved dramatically over the past 20 years. The question is no longer whether cure is possible, but rather, how can cure be best achieved. With better understanding of the biology of Hodgkin's disease and with continued evolution of treatment approaches, the goal of curing all patients with Hodgkin ...
Norbert Schmitz +3 more
openaire +6 more sources
The American Journal of Nursing, 1958
ODGKIN'S disease is the best known member of a group of malignant lymphomas, which includes lymphosarcoma, reticulum cell sarcoma, and follicular lymphoblastoma or Brill-Symmer's disease. The diagnosis can be made only by microscopic examination of a biopsied lymph node since the clinical course of these various lymphomas is quite similar, and since ...
John F. Hynes, Eleanor B. Jansson
openaire +3 more sources
ODGKIN'S disease is the best known member of a group of malignant lymphomas, which includes lymphosarcoma, reticulum cell sarcoma, and follicular lymphoblastoma or Brill-Symmer's disease. The diagnosis can be made only by microscopic examination of a biopsied lymph node since the clinical course of these various lymphomas is quite similar, and since ...
John F. Hynes, Eleanor B. Jansson
openaire +3 more sources